King SA - Search Results

1

Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.

Clancy JP, Hong JS, Bebök Z, King SA, Demolombe S, Bedwell DM, Sorscher EJ. Clancy JP, et al. Among authors: king sa. Biochemistry. 1998 Oct 27;37(43):15222-30. doi: 10.1021/bi980436f. Biochemistry. 1998. PMID: 9790686

2

Recombinant synthesis of cystic fibrosis transmembrane conductance regulator and functional nucleotide-binding domains.

King SA, Sorscher EJ. King SA, et al. Methods Enzymol. 1998;292:686-97. doi: 10.1016/s0076-6879(98)92053-5. Methods Enzymol. 1998. PMID: 9711592 No abstract available.

3

The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.

Bebök Z, Mazzochi C, King SA, Hong JS, Sorscher EJ. Bebök Z, et al. Among authors: king sa. J Biol Chem. 1998 Nov 6;273(45):29873-8. doi: 10.1074/jbc.273.45.29873. J Biol Chem. 1998. PMID: 9792704 Free article.

4

R-domain interactions with distal regions of CFTR lead to phosphorylation and activation.

King SA, Sorscher EJ. King SA, et al. Biochemistry. 2000 Aug 15;39(32):9868-75. doi: 10.1021/bi992807d. Biochemistry. 2000. PMID: 10933805

5

Membrane transplantation to correct integral membrane protein defects.

Curlee KV, Hong JS, Clancy JP, King SA, Hunter E, Berdiev B, Benos D, Sommerfelt MA, Sorscher EJ, Sakalian M. Curlee KV, et al. Among authors: king sa. J Mol Med (Berl). 2003 Aug;81(8):511-20. doi: 10.1007/s00109-003-0446-7. Epub 2003 Jul 23. J Mol Med (Berl). 2003. PMID: 12879148

6

Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro.

Bebök Z, Abai AM, Dong JY, King SA, Kirk KL, Berta G, Hughes BW, Kraft AS, Burgess SW, Shaw W, Felgner PL, Sorscher EJ. Bebök Z, et al. Among authors: king sa. J Pharmacol Exp Ther. 1996 Dec;279(3):1462-9. J Pharmacol Exp Ther. 1996. PMID: 8968372

7

The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis.

Meacham GC, Lu Z, King S, Sorscher E, Tousson A, Cyr DM. Meacham GC, et al. EMBO J. 1999 Mar 15;18(6):1492-505. doi: 10.1093/emboj/18.6.1492. EMBO J. 1999. PMID: 10075921 Free PMC article.

8

Development of drug targeting based on recombinant expression of the chicken avidin gene.

Walker L, Kulomaa MS, Bebok Z, Parker WB, Allan P, Logan J, Huang Z, Reynolds RC, King S, Sorscher EJ. Walker L, et al. J Drug Target. 1996;4(1):41-9. doi: 10.3109/10611869609046259. J Drug Target. 1996. PMID: 8798877

9

Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase.

Hughes BW, King SA, Allan PW, Parker WB, Sorscher EJ. Hughes BW, et al. Among authors: king sa. J Biol Chem. 1998 Jan 23;273(4):2322-8. doi: 10.1074/jbc.273.4.2322. J Biol Chem. 1998. PMID: 9442077 Free article.

10

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.

Parker WB, King SA, Allan PW, Bennett LL Jr, Secrist JA 3rd, Montgomery JA, Gilbert KS, Waud WR, Wells AH, Gillespie GY, Sorscher EJ. Parker WB, et al. Among authors: king sa. Hum Gene Ther. 1997 Sep 20;8(14):1637-44. doi: 10.1089/hum.1997.8.14-1637. Hum Gene Ther. 1997. PMID: 9322865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters